Massachusetts Financial Services’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $179K | Sell |
57,511
-124,345
| -68% | -$387K | ﹤0.01% | 875 |
|
|
2025
Q1 | $615K | Sell |
181,856
-4,144
| -2% | -$14K | ﹤0.01% | 836 |
|
|
2024
Q4 | $1.05M | Buy |
186,000
+14,144
| +8% | +$80.2K | ﹤0.01% | 815 |
|
|
2024
Q3 | $1.01M | Buy |
171,856
+28,333
| +20% | +$166K | ﹤0.01% | 794 |
|
|
2024
Q2 | $1.14M | Buy |
143,523
+4,816
| +3% | +$38.1K | ﹤0.01% | 788 |
|
|
2024
Q1 | $1.29M | Buy |
138,707
+27,781
| +25% | +$259K | ﹤0.01% | 761 |
|
|
2023
Q4 | $936K | Sell |
110,926
-3,505
| -3% | -$29.6K | ﹤0.01% | 774 |
|
|
2023
Q3 | $887K | Buy |
+114,431
| New | +$887K | ﹤0.01% | 772 |
|
|
2021
Q2 | – | Sell |
-54,878
| Closed | -$258K | – | 943 |
|
|
2021
Q1 | $258K | Sell |
54,878
-57,705
| -51% | -$271K | ﹤0.01% | 903 |
|
|
2020
Q4 | $805K | Sell |
112,583
-1,129
| -1% | -$8.07K | ﹤0.01% | 811 |
|
|
2020
Q3 | $1.21M | Sell |
113,712
-4,457
| -4% | -$47.5K | ﹤0.01% | 764 |
|
|
2020
Q2 | $1.49M | Buy |
+118,169
| New | +$1.49M | ﹤0.01% | 709 |
|